Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Army
Cantor Fitzgerald
Express Scripts
Colorcon
Queensland Health
McKinsey
Moodys
Covington
Chinese Patent Office

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,466,972

« Back to Dashboard

Summary for Patent: 4,466,972
Title: Benzoxadiazoles and benzothiadiazoles, their preparation and pharmaceutical compositions containing them
Abstract:Compounds of formula I, ##STR1## wherein X is oxygen or sulphur, and R.sub.1 -R.sub.6 are various substituents. The compounds are useful for treating coronary insufficiency, intermittent claudication, cerebrovascular insults, spasms in muscles and hypertension.
Inventor(s): Neumann; Peter (Berne, CH)
Assignee: Sandoz Ltd. (Basel, CH)
Application Number:06/359,751
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

Drugs Protected by US Patent 4,466,972

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,466,972

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Switzerland7520/77Jun 20, 1977
Switzerland2865/78Mar 16, 1978
Switzerland5627/79Jun 15, 1978
Switzerland12835/78Dec 18, 1978
Switzerland12888/78Dec 18, 1978
Switzerland12890/78Dec 18, 1978
Switzerland3472/79Apr 11, 1979
Switzerland3477/79Apr 11, 1979
United Kingdom40624/79Nov 23, 1979
Germany294945Dec 08, 1979

International Patents Family Members for US Patent 4,466,972

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 376220 ➤ Try a Free Trial
Austria A443178 ➤ Try a Free Trial
Australia 3725278 ➤ Try a Free Trial
Australia 524000 ➤ Try a Free Trial
Australia 536055 ➤ Try a Free Trial
Australia 538515 ➤ Try a Free Trial
Australia 5389679 ➤ Try a Free Trial
Australia 5389779 ➤ Try a Free Trial
Australia 545685 ➤ Try a Free Trial
Australia 6460380 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Covington
Fuji
AstraZeneca
UBS
Harvard Business School
Johnson and Johnson
US Department of Justice
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot